Peiqing Liu Selected Research

Isoproterenol (Isoprenaline)

5/2022	MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B.
2/2022	MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
1/2022	Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes.
10/2021	Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3.
5/2021	The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy.
1/2020	PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression.
1/2019	Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.
12/2018	JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.
12/2018	Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
12/2016	The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peiqing Liu Research Topics

Disease

33	Hypertrophy 05/2022 - 10/2008
33	Fibrosis (Cirrhosis) 12/2021 - 04/2007
28	Cardiomegaly (Heart Hypertrophy) 05/2022 - 05/2007
25	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 12/2006
18	Neoplasms (Cancer) 01/2022 - 01/2012
17	Inflammation (Inflammations) 06/2022 - 01/2011
16	Atherosclerosis 02/2020 - 02/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 03/2009
9	Alzheimer Disease (Alzheimer's Disease) 12/2014 - 08/2008
7	Heart Failure 10/2021 - 02/2014
6	Adenoviridae Infections (Adenovirus Infections) 07/2018 - 09/2016
5	Cardiotoxicity 03/2021 - 01/2019
5	Myocardial Infarction 02/2019 - 10/2012
4	Rheumatoid Arthritis 12/2017 - 06/2009
4	Atherosclerotic Plaque (Atheroma) 12/2015 - 11/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2016
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2016
3	Breast Neoplasms (Breast Cancer) 02/2020 - 01/2014
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2019
3	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2019 - 01/2016
3	Hypertension (High Blood Pressure) 01/2019 - 05/2007
3	Arthritis (Polyarthritis) 01/2017 - 02/2013
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2022
2	Liver Neoplasms (Liver Cancer) 01/2021 - 11/2018
2	Pathologic Processes 01/2021 - 07/2014
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	COVID-19 12/2020 - 07/2020
2	Heart Diseases (Heart Disease) 01/2019 - 10/2008
2	Infections 01/2019 - 04/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
13	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2011
13	Angiotensin IIIBA 01/2018 - 05/2007
12	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2022 - 01/2014
11	Fibronectins (Fibronectin)IBA 01/2019 - 12/2006
9	cryptotanshinoneIBA 03/2022 - 03/2009
9	Messenger RNA (mRNA)IBA 01/2022 - 02/2012
8	Pharmaceutical PreparationsIBA 03/2022 - 02/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
8	tanshinoneIBA 07/2014 - 11/2011
7	CytokinesIBA 12/2020 - 06/2009
7	ApolipoproteinsIBA 02/2020 - 11/2011
7	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2009
6	Biological ProductsIBA 01/2022 - 12/2010
6	CateninsIBA 01/2022 - 01/2011
6	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022 - 03/2015
6	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 01/2019
6	Sirtuin 1IBA 01/2020 - 01/2013
6	Advanced Glycation End ProductsIBA 01/2018 - 12/2013
6	sphingosine kinaseIBA 10/2017 - 10/2010
6	BerberineIBA 01/2016 - 01/2011
6	oxidized low density lipoproteinIBA 12/2015 - 10/2010
5	EnzymesIBA 01/2021 - 07/2015
5	LipidsIBA 02/2020 - 07/2014
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2014
5	NF-kappa B (NF-kB)IBA 01/2020 - 10/2012
5	Small Interfering RNA (siRNA)IBA 07/2018 - 01/2011
5	CholesterolIBA 12/2014 - 02/2010
4	Sirtuin 3IBA 03/2022 - 10/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2014
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 09/2016
4	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 01/2020 - 07/2015
4	Extracellular Matrix ProteinsIBA 01/2019 - 12/2011
4	Atrial Natriuretic Factor (ANF)IBA 12/2018 - 02/2014
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 01/2016
4	Apolipoproteins E (ApoE)IBA 12/2015 - 11/2011
4	Endothelin-1 (Endothelin 1)IBA 02/2014 - 10/2008
3	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2019
3	Connexin 43 (Connexin43)IBA 01/2021 - 05/2013
3	AntioxidantsIBA 02/2020 - 01/2012
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 05/2007
3	Casein Kinase II (Casein Kinase 2)IBA 01/2018 - 01/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2013
3	Therapeutic UsesIBA 01/2017 - 02/2014
3	polydatinIBA 01/2017 - 10/2012
3	Collagen Type II (Type II Collagen)IBA 01/2017 - 02/2013
3	SirtuinsIBA 09/2016 - 01/2016
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016 - 10/2010
3	Sphingosine-1-Phosphate ReceptorsIBA 01/2016 - 05/2012
3	PPAR alphaIBA 05/2013 - 07/2007
3	Amyloid (Amyloid Fibrils)IBA 03/2012 - 08/2008
2	Sirolimus (Rapamycin)FDA Link 02/2022 - 01/2014
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2012
2	Sorting NexinsIBA 10/2021 - 12/2017
2	LipopolysaccharidesIBA 12/2020 - 01/2011
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 11/2020 - 01/2020
2	Tamoxifen FDA LinkGeneric 02/2020 - 01/2011
2	Protein Isoforms (Isoforms)IBA 01/2020 - 11/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 02/2014
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2016
2	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019 - 05/2014
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 02/2014
2	Dinoprostone (PGE2)FDA Link 01/2018 - 02/2014
2	NF-E2-Related Factor 2IBA 01/2018 - 01/2017
2	CalciumIBA 01/2018 - 05/2014

Therapy/Procedure

15	Therapeutics 03/2022 - 05/2009
4	Drug Therapy (Chemotherapy) 01/2022 - 07/2019